Ocata Therapeutics Inc fka OCAT

[elllk]

Approval means NIH is allowed to fund research using those lines if they deem the research worthy in other respects. NIH will not fund hESC research using other than approved lines. But projects using the approved lines must still meet other NIH criteria for projects worthy of funding. Of course, if the ACTC lines are approved that means ACTC could apply for NIH funding for their research projects using those lines. It also means that any other organizations using the ACTC lines in their research could apply for NIH funding for those projects. In no way does using approved lines provide, by itself, for NIH funding of a project. But, again, with approved lines ACTC has a chance, and probably a good one, at getting NIH funding for some of its projects. Approval would also make the lines more attractive to other organizations doing hESC research and would therefore make it more likely that ACTC would earn additional revenue through providing the lines to other organizations. And some of those other organizations may be especially interested in the NED (No Embryo Destruction) lines. As well, many hESC research organizations may agree with Dr. Caldwell's recent assertion that ACTC lines may have a corner in the market because of their purity. If so, that would make them that much more valuable.


Here is the site for lines approved:

http://grants.nih.gov/stem_cells/registry/current.htm


Here is the site for lines with review pending:

http://grants.nih.gov/stem_cells/registry/pending.htm